12.9 USD
0 (0%)
At close: Jan 30, 2026
12.9 USD
0 (0%)
After Hours: 1/30/2026, 8:00:02 PM
ChartMill assigns a Buy % Consensus number of 83% to ENTA. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 19.51. This target is 51.22% above the current price.
- ENTA was analyzed by 14 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ENTA.
- In the previous month the buy percentage consensus was at a similar level.
- ENTA was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-11-14 | JP Morgan | Initiate | Overweight |
| 2025-09-30 | WestPark Capital | Maintains | Buy -> Buy |
| 2025-09-15 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-09-02 | WestPark Capital | Initiate | Buy |
| 2025-08-12 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-06-03 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-02-11 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-02-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-24 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-26 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-11-26 | Baird | Maintains | Outperform -> Outperform |
| 2024-10-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-09 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-09-27 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-08-06 | JP Morgan | Maintains | Underweight -> Underweight |
| 2024-08-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-07 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-05-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-02-08 | JP Morgan | Maintains | Underweight -> Underweight |
| 2023-11-22 | Oppenheimer | Maintains | Perform -> Perform |
| 2023-11-21 | JMP Securities | Maintains | Outperform -> Outperform |
| 2023-11-21 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-10-23 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-10-02 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2023-09-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-09 | Oppenheimer | Maintains | Perform -> Perform |
| 2023-08-08 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2023-08-08 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2023-08-08 | Jefferies | Downgrade | Buy -> Hold |
ENANTA PHARMACEUTICALS INC / ENTA FAQ
Can you provide the average price target for ENANTA PHARMACEUTICALS INC stock?
14 analysts have analysed ENTA and the average price target is 19.51 USD. This implies a price increase of 51.22% is expected in the next year compared to the current price of 12.9.
How do analysts rate ENANTA PHARMACEUTICALS INC (ENTA)?
The consensus rating for ENANTA PHARMACEUTICALS INC (ENTA) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed ENANTA PHARMACEUTICALS INC (ENTA)?
The number of analysts covering ENANTA PHARMACEUTICALS INC (ENTA) is 14.